Accutane :: FDA’s Web Page Warning Against Buying Accutane
The U.S. Food & Drug Administration (FDA) is launching a special Web page to warn consumers about the dangers of buying isotretinoin (Accutane) online.
Food
IBS :: FDA discontinues marketing of GI drug, Zelnorm, for safety reasons
The Food and Drug Administration (FDA) has requested that Novartis Pharmaceuticals Corporation of East Hanover, New Jersey, voluntarily discontinue marketing of Zelnorm (tegaserod) based on the recently identified finding of an increased risk of serious cardiovascular adverse events (heart problems) associated with use of the drug.
Clotting Disorder :: FDA approves Ceprotin biologic to treat rare clotting disorder
The U.S. Food and Drug Administration (FDA) licensed Ceprotin, the first biologic treatment for patients with a rare genetic defect that can cause a potentially life-threatening clotting disorder.
Schizophrenia :: Safety analyses of clinical data for bifeprunox in patients with schizophrenia
Solvay Pharmaceuticals, Inc., Wyeth Pharmaceuticals, a division of Wyeth (NYSE:WYE), and Lundbeck A/S presented clinical study results on bifeprunox at an international medical congress this week.
Drugs :: New chemistry approach promises less expensive drugs
With a newly discovered method of assembling organic molecules, a team of Princeton University chemists may have found a way to sidestep many of the expensive and hazardous barriers that stand in the way of drug development.
Cervical Cancer :: GlaxoSmithKline’s Cervarix vaccine for cervical cancer
GlaxoSmithKline GSK announced that the company has submitted a Biologics License Application (BLA) for CERVARIX(R) (human papillomavirus vaccine, AS04 adjuvant-adsorbed), its cervical cancer candidate vaccine, to the U.S. Food and Drug Administration (FDA).
Fish :: Health Canada revises assessment of mercury in fish
Health Canada has completed a review of the science on mercury in fish, and is putting additional measures in place to protect Canadians while encouraging them to follow the fish consumption advice contained in the new Food Guide.
Prostate Cancer :: Dendreon’s Provenge for Hormone Refractory Prostate Cancer
Dendreon Corporation (Nasdaq: DNDN) announced that the U.S. Food and Drug Administration’s (FDA) Office of Cellular, Tissue and Gene Therapies Advisory Committee recommended to the FDA that there is substantial evidence of efficacy and safety of PROVENGE (sipuleucel-T) for the treatment of patients with asymptomatic, metastatic, androgen-independent (also known as hormone refractory) prostate cancer.
Parkinson’s Disease :: FDA announces voluntary withdrawal of Pergolide products
The U.S. Food and Drug Administration (FDA) announced that manufacturers of pergolide drug products, which are used to treat Parkinson’s disease, will voluntarily remove these drugs from the market because of the risk of serious damage to patients? heart valves.
Memory :: New research shows why too much memory may be a bad thing
New research from Columbia University Medical Center may explain why people who are able to easily and accurately recall historical dates or long-ago events, may have a harder time with word recall or remembering the day?s current events.